Objective: We undertook this study to determine whether thrombin-cleaved osteopontin (OPN) in synovial fluid (SF) represents a useful marker of osteoarthritis (OA) progression in the posterior cruciate ligament transection (PCLT) OA rabbit model. Method: PCLT was performed on the right knee joints of 48 rabbits. The rabbits were then sacrificed separately at 4, 8, 16, and 24 weeks post-surgery, when the joint was harvested and macroscopic and histological assessments of articular cartilage were performed. Thrombin-cleaved OPN product in SF was determined using Western blotting and the levels were measured using an enzyme-linked immunoassay. Results: The macroscopic and histological scores for PCLT knees were already elevated 4 weeks after surgery and increased with time. Western blotting showed the presence of thrombin-cleaved OPN in SF from PCLT knees. Thrombin-cleaved OPN levels in SF were elevated at 4 weeks (P < 0.001) and were elevated peaking at 24 weeks (P < 0.00001) after PCLT compared to baseline. A positive significant correlation was found between thrombin-cleaved OPN levels and the macroscopic scores (8 weeks: r ¼ 0.695, P ¼ 0.012; 16 weeks: r ¼ 0.751, P ¼ 0.005; 24 weeks: r ¼ 0.660, P ¼ 0.020). Furthermore, the same correlation was noted between thrombin-cleaved OPN levels and the histological scores (4 weeks: r ¼ 0.609, P ¼ 0.036; 8 weeks: r ¼ 0.662, P ¼ 0.019; 16 weeks: r ¼ 0.827, P ¼ 0.001; 24 weeks: r ¼ 0.813, P ¼ 0.001). Conclusion: In this rabbit model of PCLT, thrombin-cleaved OPN levels in SF appear to provide a useful marker of OA disease severity and progression.
Introduction
Osteoarthritis (OA) is thought to be the most prevalent chronic joint disease. Worldwide estimates are that about 10% of men and 18% of women and about 60e65% aged over 60 years have symptomatic OA and 80% of those have limitations in movement. Diagnosis of OA relies mainly on clinical examination and radiographic measures. Radiographic measures, however, are less than adequate for diagnosing and assessing the actual progress of this disease. Despite efforts over the past decades to develop markers of disease, biochemical marker still need to be improved and possibly extended with more specific and sensitive methods to diagnose the disease at an early stage, reliably follow the course of disease and evaluate efficacy of disease-modifying agents 1, 2 .
Osteopontin (OPN) is an extracellular matrix glycoprotein that has been recognized as a potential inflammatory cytokine. OPN is abundant in bone and can be secreted by many cell types such as osteoclasts, macrophages, lymphocytes, epithelial cells and vascular smooth muscle cells (SMCs) 3, 4 . The function of OPN is modulated by protease digestion, and a thrombin-cleaved form of OPN is involved in the pathogenesis of various inflammatory disorders. The biomarker has been studied in vivo in rat 5 , healthy human and OA patients 6, 7 and also rheumatoid arthritis (RA) patients 8 . The thrombin-cleaved form of OPN may be involved in the molecular pathogenesis of OA, contributing to progressive degeneration of articular cartilage 8, 9 .
Surgically induced destabilization of joints is the most widely used induction method, where the underlying initiating mechanism is altered mechanical loading, one of the most common causes of secondary OA in humans. Many induction methods actually copy known injuries in humans, such as anterior cruciate ligament transection (ACLT) and meniscectomy. As a long-term complication, many patients with posterior cruciate ligament (PCL) injuries eventually develop OA in the injured knee joint 10, 11 . Posterior cruciate ligament transection (PCLT) can also replicate the naturally occurring sequence of the disease process of human OA and has been used as a model in previous studies 12e15 .
The purpose of this study was to investigate the changes over time of thrombin-cleaved OPN in synovial fluid (SF) during the development of OA induced by PCLT in rabbits. We hypothesized that the levels of thrombin-cleaved OPN were correlated with the macroscopic and histological changes that occurred in this model. This study aimed at adding important details for the validation of these specific OA biomarkers.
Materials and methods

Experimental group
The experiment was absolutely approved by the Institutional Animal Care and Use Committee of Xiangya Hospital, Central South University (Changsha, China) and the animals were cared for in the Experimental Animal Center of Xiangya Hospital. 48 mature white rabbits (male, 2.5 AE 0.4 kg, 6 months old) were used. The rabbits were acclimated to conditions for 1 week before the experiment and were housed individually at 25 C with a 12:12-h lightedark cycle and had free access to tap water and commercial rabbit diet. Surgical transection of the PCL of the right knee was performed under general anesthesia as previously reported 14 . Postoperatively, the rabbits were housed and they had free access to exercise in a large enclosure. For each rabbit, sodium aminobenzyl penicillin (500 mg) was administered intramuscularly daily for 7 days postoperatively. The rabbits were sacrificed by an intravenous injection of barbiturates 4, 8, 16 and 24 weeks after the surgical procedure.
Macroscopic grading
After the rabbits were sacrificed, each knee was harvested and evaluated macroscopically by two independent, blinded investigators using the grading system of Tibesku et al. 16 , consisting of four different criteria: fibrillations and ulcerations of the hyaline cartilage, osteophyte formation, and joint effusion. Scores for fibrillations ranged from 0 for intact hyaline cartilage to 3 for marked fibrillations, scores for ulcerations ranged from 0 for normal to 2 for a large area of ulceration, scores for osteophyte formation ranged from 0 for no osteophytes to 3 for marked osteophyte formation, and scores for joint effusion ranged from 0 for no effusion to 3 for marked effusion. The total score ranged from 0 to 11, with 0 being a macroscopically intact knee joint and 11 being significant OA.
Histologic grading
Cartilage was removed from the areas of the lesions identified by the macroscopic grading and then histologic evaluation was performed on sagittal sections of cartilage from the lesions of the femoral condyles and tibial plateaus. The specimens were dissected, fixed in 4% paraformaldehyde for 2 days. After decalcification with buffered ethylene diamine tetraacetic acid (EDTA), the samples then sequentially dehydrated in alcohol and embedded into paraffin blocks. Sections were cut at a thickness of 5 mm, mounted to the center of the glass slide, deparaffinized in xylene, and washed three times with distilled water and then with Tris-buffered saline for 2 min. Sections were stained with hematoxylin and eosin (H&E) or with safranin Oefast green to evaluate histologic changes of the cartilage and bone tissue according to the osteoarthritis research society international (OARSI) histopathology initiative (Table I) 17 .This scale evaluates the severity of OA lesions based on safranin Oefast green staining (scale 0e6), structure (scale 0e11), chondrocyte density (scale 0e4), and cluster formation (scale 0e3). The final score corresponds to the score of the most severe lesions. The examination was performed by two independent researchers in a blind manner. and the knees moved five times through a full range of motions. SF samples were centrifuged at 3000 rpm in a micro-centrifuge prior to freezing and were kept frozen at À70 C until the biomarker analysis was performed. Western blot analyses of SF were performed to examine the presence of thrombin-cleaved OPN (OPN N-half). 0.1 ml each sample was diluted twice with phosphate-buffered saline (PBS) and loaded onto gels, incubated in blocking buffer (PBS, 5% non-fat dry milk, 0.05% Tween 20) for 1 h at room temperature, washed five times with PBS, and then eluted with 1.0 ml of 0.7 M NaCl in PBS. The elutes were diluted twice with 2Â sodium dodecyl sulfate (SDS) gel-loading buffer (100 mM Tris HCl, pH 6.8, 4% SDS, 20% glycerol), boiled, and applied on Western blotting with horseradish peroxidase (HRP)-labeled rabbit anti-mouse OPN polyclonal antibody (O-17) raised against LPVKVTDSGSSEEKLY peptide (Uscnlife Science & Technology Company, China).
Double-blined quantitative detection of thrombin-cleaved OPN (OPN N-half) in SF was performed using commercial ELISA (Uscnlife Science & Technology Company, China) according to the manufacturers' instructions. Briefly, 96-well microtiter plates were coated with anti-OPN N-half mouse monoclonal antibody (in 0.1 M carbonate buffer, pH 9.5) at 4 C overnight, then blocked with 1% bovine serum albumin in PBS at 4 C overnight. The mouse monoclonal antibody (34E3) specifically reacts to SLAYGLR and SVVYGLR, exposed by thrombin cleavage of mouse and human OPN, respectively. The wells were then washed seven times with washing buffer and incubated for 30 min at 4 C with a HRP-labeled rabbit anti-mouse OPN polyclonal antibody (O-17). After nine washes, substrate solution was added to each well and the plate was incubated for 30 min at room temperature in the dark. Finally, color development was stopped by addition of stop solution. The optical density of each sample was measured at 450 nm. Each data was evaluated by three independent experiments. The assays had intraassay coefficients of variation <5% and inter-assay coefficients of variation <8%
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Statistical analysis
Macroscopic and histological scores were expressed as mean AE standard deviation (SD). The levels of thrombin-cleaved OPN were expressed as median and 95% confidence interval (CI). Statistical analysis was performed using GraphPad InStat 3. Friedman test followed by the Dunn's multiple comparison post-test was used to analyze the variation of the biomarker concentration. Correlations between thrombin-cleaved OPN levels in SF and the other evaluated parameters were established using the nonparametric Spearman's rank correlation coefficient. P-values less than 0.05 were taken as statistically significant.
Results
Macroscopic and histologic analyses
Macroscopically visible surface fibrillation and focal erosions were observed as early as 4 weeks after PCLT in the femorotibial joint. The histological evaluation illustrated the OA lesion observed with the macroscopic observation (Fig. 1) . These characteristics of OA progressed gradually at later time points, predominantly on the medial tibial plateau and medial femur. The macroscopic and histological scores of cartilage from PCLT knees were already elevated 4 weeks after surgery and increased with time (Table II) .
The protein expression of thrombin-cleaved OPN
The protein expressions of thrombin-cleaved OPN are shown in (Fig. 4) .
Discussion
This study revealed a marked increase of thrombin-cleaved OPN levels in SF after PCLT compared with the baseline. Elevated levels of OPN in the SF were possibly caused by either the release of OPN residing in the local tissues, including the synovium, bone, and articular cartilage, or the increase in its production, or both 7, 10 .
Previous studies have demonstrated the immunohistochemical expression of OPN in the synovial lining cells 19 , fibroblasts in the synovial tissues 20 and articular chondrocytes 20 . It is suggested that cell adhesion, migration or inflammation could be involved in the release of OPN 21 . Proinflammatory cytokines have been demonstrated to play a pivotal role in the development of the disease process. Xu et al. 22 reported overexpression of OPN induces proinflammatory chemokines and cytokines (e.g., IL-1, IL-8, CXCL1, CCL2, and so on) and activates nuclear factor-kappa B pathway. Sharif et al. 8 showed that increased levels of thrombin-cleaved OPN correlated with increased levels of multiple proinflammatory cytokines including TNF-a and IL-6. Thus, elevated levels of thrombin-cleaved OPN may play a significant role in the pathogenesis of OA. Previous study 23 also showed administration of an antibody directed against the SLAYGLR sequence, exposed by thrombin cleavage of murine OPN, inhibited synovitis, bone erosion, inflammatory cell infiltration in arthritic joints of animal models of RA and reduced the expression of inflammatory cytokine (IL-1b, TNF-a, IL-6, and IL-10). Another very recent study 24 showed that the SVVYGLR sequence induces pro-MMP9 expression in isolated vascular SMCs and in diabetic mouse aortas. In addition, the SVVYGLR peptide has been shown to induce angiogenesis of in vitro and in vivo 25 . These studies suggested that a SLAYGLR epitope within OPN is involved in inflammatory cell migration, differentiation and activation of osteoclast, inflammatory cytokine production and synovial proliferation. However, antibodies recognizing full-length OPN also inhibit development of arthritis 26 . Thrombin has various proinflammatory activities, including cytokine release through activation of the receptors on cells. Tissue factor expression and fibrin deposition are common features of inflamed synovium in RA and OA, which indicates generation of thrombin in the lesions and suggests an involvement of thrombin in the joint inflammation. Sharif et al. 8 considered thrombin was generated and cleaves OPN to OPN-R (SLAYGLR) following initial insult, which enhanced tissue inflammation. Alternatively, thrombin can also bind to thrombomodulin on the synovial cell surface, which then activated thrombin-activatable procarboxypeptidase B (pCPB) locally to thrombin-activatable carboxypeptidase B (CPB) and converted OPN-R (SLAYGLR) to OPN-L (SVVYGL), thereby dampening inflammation. Myles et al. found OPN cleavage by thrombin was dependent on both of the anion-binding exosites in thrombin that determined rates and specificity of thrombin proteolysis. Their results suggested OPN was a bona fide substrate for thrombin, and generation of thrombincleaved OPN with enhanced proinflammatory properties provided another molecular link between coagulation and inflammation. The intact and thrombin-cleaved forms of OPN (SVVYGLR sequence) are recognized by a4b1 integrins, while only the thrombin-cleaved form of OPN (but not intact OPN) binds to a9b1 integrins 28 . Since synovial fibroblasts express a9b1 integrin and produce its ligands, OPN and tenascin-C, it is possible that there is an autocrine and paracrine interaction of a9b1 integrin and its ligands in vivo 29 . When a blocking antibody against a9b1 integrin was given at day 3, the augmented expression of the cytokine (IL-6, TNF-a, TGF-b, IL-1b) and chemokines (CCL3, CCL4, CXCL5, CXCL12, CXCL14) was significantly reduced 29 , indicating that a9b1 integrinmediated signaling in vivo leads to the production of inflammatory molecules. In addition, bone absorption, a critical outcome of arthritis, was inhibited by a9b1 integrin antibody treatment 28 .
These studies indicated the interaction of the cleaved form of OPN and a9b1 integrin leads to the secretion of cytokine and chemokine, contributing the development of inflammatory tissue destruction. This mechanism, mediated by thrombin-cleaved OPN, is also likely to play a key role in OA. Thus, abrogation of the interaction between cleaved form of OPN or tenascin-C and a9b1 integrin by specific antibodies or knock-down of protein or gene expression of OPN, tenascin-C, or a9b1 integrin by siRNA may be a novel therapeutic means for the treatment of OA in the future. We have demonstrated that elevated levels of thrombin-cleaved OPN in SF correlated with macroscopic and histological scores of OA. Therefore, only by detecting the levels of thrombin-cleaved OPN in SF, it may be predictive of the degree of cartilaginous damage. In accordance with our observations, Hasegawa et al. 9 have Fig. 4 . Correlation of SF levels of thrombin-cleaved OPN with macroscopic and histological scores. At 4 weeks, thrombin-cleaved OPN levels were found to be significantly correlated with the histological scores. At 8, 16, 24 weeks, thrombin-cleaved OPN levels were correlated with the macroscopic and histological scores.
showed that statistically significant correlation was found between thrombin-cleaved OPN and disease severity by KellgreneLawrence grade. Honsawek et al. 30 also showed that OPN in plasma and SF was related to progressive joint damage in knee OA. These findings indicate that measurements of synovial levels of thrombin-cleaved OPN could possibly serve as a biochemical parameter for determining disease severity and may be predictive of prognosis with respect to the progression of osteoarthritic disease process. Matsui et al. 5 showed that both structural changes and an increased loss of proteoglycan from cartilage tissue were augmented in the absence of OPN. OPN deficiency also led to the induction of matrix metalloproteinase 13 (MMP-13), which degraded a major component of the cartilage matrix protein type II collagen. They demonstrated that OPN could be a critical intrinsic regulator of cartilage degradation and that OPN deficiency resulted in accelerated development of OA-like tenascin-C deficiency. Okamura et al. 31 revealed that cartilage repair in tenascin-C knockout mice was significantly slower than that in WT mice and that the deficiency of tenascin-C progressed during cartilage degeneration. Nakoshi et al. 32 indicated that the distribution of tenascin-C was related to chondroitin sulfate production and chondrocyte proliferation in osteoarthritic cartilage and that tenascin-C had effects on DNA synthesis, proteoglycan content, and aggrecan mRNA expression in vitro. They considered tenascin-C may be responsible for repair in human osteoarthritic cartilage. These findings and our results suggested remodeling of cartilage could play some role in the elevated levels of thrombin-cleaved OPN.
There was considerable individual variation in the levels of thrombin-cleaved OPN detected at 16 and 24 weeks post-PCL transaction (with some at 8 weeks). Some animals were potentially so different from others for the following reasons. First, animals were not equally disabled by PCLT, nor they all developed severe OA at 16 and 24 weeks post-PCL transaction. Identical PCLT may result in inter-animal variations in instability and OA. Secondly, the degree of OA development following PCLT may also vary directly with the degree of biomechanical abnormality between individuals. Thirdly, a transected PCL can individually heal spontaneously and did not develop severe OA. Fourthly, the transection of PCL in some animals may be not completed successfully and result in inter-animal variations in the degree of OA. Therefore, some animals had lower histological scores at 16 and 24 weeks post-PCL transaction (with some at 8 weeks) in this study. Moreover, there was correlation between OPN-cleavage levels and histological scores at these points. Consequently, lower levels of thrombin-cleaved OPN in these animals were also noted.
Whereas interesting, this is important to pursue these investigations in order to test variations of the biomarker in longer range studies and in comparison with a control group. Furthermore, it would be valuable to measure levels of thrombin-cleaved OPN in serum and urine. Further investigations are under way in our laboratory to define the signaling events induced by OPN and potential experimental strategies for the inhibition of OPNmediated OA process. In addition, thrombin has various proinflammatory activities and the thrombin level in SF is probably a feasible marker to monitor ongoing joint inflammation 33 . Based on the above major point discussed regarding thrombin levels, measuring thrombin levels in SF from these animals to address those issues is necessary in the future.
In summary, our results demonstrated that thrombin-cleaved OPN levels in SF appeared to provide a useful marker of OA disease severity and progression in this rabbit model of PCLT. This study added information regarding the validity of thrombincleaved OPN. It should be further studied in human in order to test their ability to reflect the natural course of OA and to complete our previous study in human 7 .
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